Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05612256 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electrical Impedance Tomography for Identification of Optimal Positive End-expiratory Pressure in Newborn Infants

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Primary and study completion dates: Aug 2024 to Dec 2026v4
  3. Re-verified, no change to tracked fieldsv3
  4. Start date: May 16, 2022 to Dec 10, 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Electrical impedance tomography (EIT) enables assessment of regional lung ventilation at the bedside. EIT has been safely used in newborn infants to image intrathoracic lung volume patterns as early as from the first minute of life. This prospective single-centre observational study is to identify optimal PEEP in infants on respiratory support by measurements of EIT, FOT and SOPI.
Trial Details
NCT Number NCT05612256
Lead Sponsor University Children's Hospital Basel
Conditions
(from sponsor)		 Positive End-expiratory Pressure (PEEP)
Related terms Ventilator-Induced Lung Injury
Enrollment 86 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov